The Wall Street Journal last week revealed allegations from a sealed 2002 lawsuit against Medtronic that depict an extraordinary menu of kickbacks paid to doctors who used the company’s medical devices.  The Journal’s account of the complaint filed by pla

Lilly to disclose payments to docs over $500 This week, Eli Lilly announced it will begin disclosing publicly amounts it pays to physicians for speaking engagements and consulting services next year, making it the first major pharmaceutical company to do

Back in August, we reported that three PAL coalition members, Sergeants Benevolent Association Health and Welfare Fund, AFSCME District Council 37 Health & Security Plan and IUOE Local 4 Health and Welfare Fund, filed an objection to a proposed $40 millio

Drug companies are required by federal law to extend discounts that they give to health plans, hospitals and other private purchasers to Medicaid and other government health care programs. This is based on the idea that government programs should get as

Today, two Vermont groups, the Vermont Association on Mental Health and the Vermont Psychiatric Association, jointly called for the trade secret exemption be stripped from the state’s pharmaceutical payment disclosure law, arguing that the clause keeps va

The LA Times ran an article today (Legal fight over drug liability law) on Wyeth v. Levine, the case being heard by the U.S. Supreme Court this fall that could very easily slam the Courthouse doors on consumers who have been injured by drug companies' fai

What should consumers know about prescription drug advertisements? It seems the FDA thinks that Americans, first and foremost, need to understand the difference between a product-claim ad and a help-seeking ad. At least, that’s the information highlighted

PAL coalition member the Annie Appleseed Project announces its 2nd annual conference. Second Annual Evidence-based CAM for Cancer Advocates January 8-10, 2009 * West Palm Beach, FL Palm Beach Airport Hilton Surveys and studies show that 60-80% of peopl

Back in March, we reported that 11 defendants in the massive In re Pharmaceutical Industry Average Wholesale Price Litigation case had agreed to settle the case against them for $125 million (11 drug companies settle AWP allegations for $125 Million").